Phone
Address
ZhengZhou (HQ), Shenzhen (R&D Center), Suzhou (R&D Center), China
Clinical Significance :
1.The therapeutic effect of Tyrosine kinase inhibitor (TKIs) was significantly improved in patients with EGFR gene amplification (80% of lung cancer).
2.The utilization of screening of NSCLC patients for TKIs treatment
3. EGFR gene amplification can also occur in lung cancer, head and neck cancer, ovarian cancer, cervical cancer, bladder cancer, esophageal cancer and other more tumors.
EGFR Normal
EGFR Amplification
Probe Description: EGFR/ Cep 7
Cat.No.: CF1011
Specification: 10 tests/box, 20 tests/box